Aimmax Therapeutics
UEI: VCBNGNMH78J9
• CAGE: 8CZ09
Overview
Awardee Type
Parent
Name
Aimmax Therapeutics
Website
Headquarters
Durham, NC
United States
United States
Most Recent Award
April 1, 2024
Calculating
Federal grant recipient
AIMMAX THERAPEUTICS INC
(UEI VCBNGNMH78J9, CAGE 8CZ09)
is headquartered in Durham NC.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in August 2016 and
federally registered in
July 2019.
Federal Award Analysis
Aimmax Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
AIMMAX THERAPEUTICS INC
Division Name
AIMMAX THERAPEUTICS, INC.
UEI
VCBNGNMH78J9
CAGE Code
8CZ09
SBA Certifications
None
Self Certifications
Asian-Pacific American Owned
Minority Owned Business
Self-Certified Small Disadvantaged Business
Woman Owned Business
Woman Owned Small Business
Minority Owned Business
Self-Certified Small Disadvantaged Business
Woman Owned Business
Woman Owned Small Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Aug. 29, 2016
Initial Registration
July 25, 2019
Last Registration
Jan. 8, 2025
Registration Activation
Jan. 8, 2025
Registration Expiration
Jan. 6, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported PSC
Accepts Credit Cards
No